Division of Pharmaceutical Technology
Division of Pharmaceutical Technology
Prof. Dr. Dagmar Fischer
The Fischer group is focussed on the development of natural and synthetic micro- and nanocarriers for drug delivery in the field of infection, inflammation and inflammation-related diseases as well as aging. A major focus is related to biopharmaceutical test systems according to the 3R principle to investigate the life cycle of drug delivery systems and the influence of the physiological environment. Furthermore, nanosafety and safe-by-design concepts as well as quality assurance concepts are provided
News
Do. 19.05.2022 DPhG Vortrag: Synergistische Effekte von Naturstoffen zur Bekämpfung multiresistenter Gramnegativer Pathogene
Do. 28.04.2022 DPhG Vortrag: AMTS bei Patienten mit oraler Antitumortherapie
27.01.2022 DPhG Vortrag “Galenische Optimierung der oralen Bioverfügbarkeit: Konzepte und Performance”
22.07.2021 DPhG Vortrag “CRISPR/Cas-Systeme – nur Chancen oder auch Risiken?”
New Sustainable Technique for Nanoparticle Formulation using Cyrene TM
Prof. Dagmar Fischer Member „Akademie für gemeinnützige Wissenschaften zu Erfurt“
Student Poster Award at ISTU 2021
The New Voigt/Fahr „Pharmazeutische Technologie“
Practical Courses under pandemic conditions
Prof. Fischer published the 5th edition of the „Die Pharmaindustrie“
Contact - Secretariat
Petra Neubarth, VA
Sekretärin
Cauerstraße 4 (Haus 6)
91058 Erlangen
91058 Erlangen
- Phone number: +49 9131 85-29551
- Email: petra.neubarth@fau.de
- Website: http://www.pharmtech.uni-erlangen.de